Focal therapy as primary treatment for localized prostate cancer: definition, needs and future. (April 2017)

• Record Type: Journal Article
• Authors: Ouzzane, Adil; Betrouni, Nacim; Valerio, Massimo; Rastinehad, Ardeshir; Colin, Pierre; Ploussard, Guillaume
• Is Part Of: Future oncology. Volume 13:Number 8(2017)
• Page Start: 727
• Page End: 741
• Publication Date: 2017-04
• Subjects: ablation -- cryotherapy -- focal therapy -- HIFU -- imaging -- laser -- MRI -- prostate cancer -- urologic/prostate -- watchful waiting; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon-2016-0229
• Languages: English
• ISSNs: 1479-6694

Abstract

Focal therapy (FT) may offer a promising treatment option in the field of low to intermediate risk localized prostate cancer. The aim of this concept is to combine minimal morbidity with cancer control as well as maintain the possibility of retreatment. Recent advances in MRI and targeted biopsy has improved the diagnostic pathway of prostate cancer and increased the interest in FT. However, before implementation of FT in routine clinical practice, several challenges are still to overcome including patient selection, treatment planning, post-therapy monitoring and definition of oncologic outcome surrogates. In this article, relevant questions regarding the key steps of FT are critically discussed and the main available energy modalities are analyzed taking into account their advantages and unmet needs.